MA29633B1 - Sels metalliques du 2'-(1h-tetrazol-5-yl)-1, 1'-biphenyl-4-carboxaldehyde - Google Patents
Sels metalliques du 2'-(1h-tetrazol-5-yl)-1, 1'-biphenyl-4-carboxaldehydeInfo
- Publication number
- MA29633B1 MA29633B1 MA30579A MA30579A MA29633B1 MA 29633 B1 MA29633 B1 MA 29633B1 MA 30579 A MA30579 A MA 30579A MA 30579 A MA30579 A MA 30579A MA 29633 B1 MA29633 B1 MA 29633B1
- Authority
- MA
- Morocco
- Prior art keywords
- carboxaldehyde
- tetrazol
- biphenyl
- metal salts
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Catalysts (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Sels métalliques de 2'-(1H-tétrazol-5-yl)-1,1'-biphényl-4-carboxaldéhyde L'invention concerne une méthode ou un procédé de fabrication d'agents de réduction de la pression sanguine, tels que le valsartan, de nouveaux intermédiaires, ainsi que les étapes de procédé de ladite synthèse. La méthode ou le procédé est conduit(e) par l'intermédiaire des nouveaux sels intermédiaires de formule (IA) : ou d'un tautomère de ceux-ci, où [Kat]n+ est un cation et n vaut 1, 2, 3, 4, 5 ou 6.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0514206.2A GB0514206D0 (en) | 2005-07-11 | 2005-07-11 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA29633B1 true MA29633B1 (fr) | 2008-07-01 |
Family
ID=34897057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA30579A MA29633B1 (fr) | 2005-07-11 | 2008-01-16 | Sels metalliques du 2'-(1h-tetrazol-5-yl)-1, 1'-biphenyl-4-carboxaldehyde |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7728024B2 (fr) |
| EP (1) | EP1912956B1 (fr) |
| JP (1) | JP2009500434A (fr) |
| KR (1) | KR20080030609A (fr) |
| CN (2) | CN101208313A (fr) |
| AR (1) | AR054823A1 (fr) |
| AT (1) | ATE504577T1 (fr) |
| AU (1) | AU2006268906B2 (fr) |
| BR (1) | BRPI0613129A2 (fr) |
| CA (1) | CA2614718A1 (fr) |
| DE (1) | DE602006021187D1 (fr) |
| EC (1) | ECSP088090A (fr) |
| ES (1) | ES2363439T3 (fr) |
| GB (1) | GB0514206D0 (fr) |
| GT (1) | GT200600303A (fr) |
| IL (1) | IL188190A0 (fr) |
| MA (1) | MA29633B1 (fr) |
| MX (1) | MX2008000465A (fr) |
| MY (1) | MY143947A (fr) |
| NO (1) | NO20080742L (fr) |
| NZ (1) | NZ564548A (fr) |
| PE (1) | PE20070248A1 (fr) |
| PL (1) | PL1912956T3 (fr) |
| PT (1) | PT1912956E (fr) |
| RU (1) | RU2435761C2 (fr) |
| SA (1) | SA06270220B1 (fr) |
| TN (1) | TNSN08005A1 (fr) |
| TW (1) | TW200745065A (fr) |
| WO (1) | WO2007006531A1 (fr) |
| ZA (1) | ZA200711023B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008004110A2 (fr) | 2006-07-03 | 2008-01-10 | Aurobindo Pharma Limited | Procédé amélioré de préparation d'un antagoniste de l'angiotensine ii |
| EP2260018A2 (fr) | 2008-04-07 | 2010-12-15 | Hetero Research Foundation | Procédé de préparation d'un intermédiaire de valsartan |
| CN103012301B (zh) * | 2013-01-05 | 2015-06-17 | 江苏施美康药业股份有限公司 | 缬沙坦甲酯碱金属盐及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0550313A1 (fr) * | 1991-12-30 | 1993-07-07 | Synthelabo | Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse |
| JP4568400B2 (ja) * | 2000-03-24 | 2010-10-27 | 株式会社日本ファインケム | 水和ヒドラジンとジシアンを原料とする５，５’−ビ−１ｈ−テトラゾールジアンモニウム塩の製造方法 |
| GB0222056D0 (en) * | 2002-09-23 | 2002-10-30 | Novartis Ag | Process for the manufacture of organic compounds |
| GB0316546D0 (en) | 2003-07-15 | 2003-08-20 | Novartis Ag | Process for the manufacture of organic compounds |
| PL1660463T3 (pl) * | 2003-08-08 | 2008-05-30 | Dipharma Francis Srl | Sposób wytwarzania pochodnych fenylotetrazolu |
| ITMI20032267A1 (it) | 2003-11-21 | 2005-05-22 | Dinamite Dipharma S P A In Forma A Bbreviata Diph | Procdimento per la preparzione di valsartan e suoi intermedi |
-
2005
- 2005-07-11 GB GBGB0514206.2A patent/GB0514206D0/en not_active Ceased
-
2006
- 2006-07-06 MY MYPI20063226A patent/MY143947A/en unknown
- 2006-07-07 PE PE2006000810A patent/PE20070248A1/es not_active Application Discontinuation
- 2006-07-07 AR ARP060102936A patent/AR054823A1/es not_active Application Discontinuation
- 2006-07-10 MX MX2008000465A patent/MX2008000465A/es active IP Right Grant
- 2006-07-10 BR BRPI0613129-8A patent/BRPI0613129A2/pt not_active IP Right Cessation
- 2006-07-10 SA SA06270220A patent/SA06270220B1/ar unknown
- 2006-07-10 ES ES06754707T patent/ES2363439T3/es active Active
- 2006-07-10 WO PCT/EP2006/006730 patent/WO2007006531A1/fr active Application Filing
- 2006-07-10 KR KR1020087000723A patent/KR20080030609A/ko not_active Application Discontinuation
- 2006-07-10 TW TW095125125A patent/TW200745065A/zh unknown
- 2006-07-10 CN CNA2006800230702A patent/CN101208313A/zh active Pending
- 2006-07-10 PT PT06754707T patent/PT1912956E/pt unknown
- 2006-07-10 EP EP06754707A patent/EP1912956B1/fr active Active
- 2006-07-10 DE DE602006021187T patent/DE602006021187D1/de active Active
- 2006-07-10 CN CNA2009100032514A patent/CN101468972A/zh active Pending
- 2006-07-10 AT AT06754707T patent/ATE504577T1/de active
- 2006-07-10 NZ NZ564548A patent/NZ564548A/en not_active IP Right Cessation
- 2006-07-10 JP JP2008520770A patent/JP2009500434A/ja active Pending
- 2006-07-10 US US11/995,240 patent/US7728024B2/en not_active Expired - Fee Related
- 2006-07-10 RU RU2008104526/04A patent/RU2435761C2/ru not_active IP Right Cessation
- 2006-07-10 AU AU2006268906A patent/AU2006268906B2/en not_active Ceased
- 2006-07-10 PL PL06754707T patent/PL1912956T3/pl unknown
- 2006-07-10 CA CA002614718A patent/CA2614718A1/fr not_active Abandoned
- 2006-07-10 GT GT200600303A patent/GT200600303A/es unknown
-
2007
- 2007-12-17 IL IL188190A patent/IL188190A0/en unknown
- 2007-12-19 ZA ZA200711023A patent/ZA200711023B/xx unknown
-
2008
- 2008-01-10 EC EC2008008090A patent/ECSP088090A/es unknown
- 2008-01-10 TN TNP2008000005A patent/TNSN08005A1/en unknown
- 2008-01-16 MA MA30579A patent/MA29633B1/fr unknown
- 2008-02-11 NO NO20080742A patent/NO20080742L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA33540B1 (fr) | Dérivés de la pyridine et de la pyrazine en tant que modulateurs de la protéine kinase | |
| KR101891494B1 (ko) | 신규 화합물 | |
| MA31084B1 (fr) | Derives de piperidine agonistes de gpcr | |
| MA29772B1 (fr) | Benzimidazoles substitues et procedes de preparation | |
| MA27906A1 (fr) | Processus de preparation de derives de tetrazole issus de bore organo et d'azides d'aluminium organo | |
| MA30411B1 (fr) | Derives de triazolopyrazine utiles comme agent anticancereux | |
| MA29620B1 (fr) | Nouveau derive de 1,4-benzothiazepine-1,1-dioxyde presentant des proprietes ameliorees, procede pour sa preparation, medicaments contenant ce compose, et son utilisation | |
| MA28687B1 (fr) | Composes organiques | |
| TN2009000544A1 (fr) | Derives de benzimidazole | |
| MA28077A1 (fr) | Derives d'isoquinilone 1,4-disubstitues en tant qu'inhibiteurs de raf-kinase utiles pour le traitement de maladies proliferantes | |
| MA30722B1 (fr) | Utilisation de derives de l'adenosine en tant qu'agonistes du recepteurs a2a | |
| MA29539B1 (fr) | Procedes de production de derives phenoliques 4-biphenylylazetidin -2-one | |
| MA30991B1 (fr) | Utilisation de dérivés du benzamide comme agonistes des récepteurs ep4 | |
| MA30075B1 (fr) | Derives de pyrimidine pour le traitement d'une croissance cellulaire anormale | |
| MA33764B1 (fr) | Procédé de fabrication du {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate de méthyle et de purification de celui-ci en vue de son utilisation comme principe actif pharmaceutique | |
| MA27883A1 (fr) | Derives de pyrido [2,1-a] isoquinoline utilises comme inhibiteurs de dpp-iv | |
| MA29633B1 (fr) | Sels metalliques du 2'-(1h-tetrazol-5-yl)-1, 1'-biphenyl-4-carboxaldehyde | |
| MA32903B1 (fr) | Inhibiteurs de proteine-kinases | |
| WO2007091009A3 (fr) | Préparation de delmopinol | |
| MA34965B1 (fr) | Procédé de production de dérivé de dihydrobenzofurane optiquement actif | |
| MA29170B1 (fr) | Derives puriniques agissant comme des agonistes du recepteur a2a | |
| MA32790B1 (fr) | Nouvelle composition a base d'acide gamma-hydroxybutyrique | |
| TNSN05309A1 (fr) | Derives d'imidazole utilises comme antagonistes du recepteur du glutamate | |
| MA31910B1 (fr) | Antagonistes des recepteurs non steroidiens des mineralocorticoides derives de la 6h-dibenzo[b,e]oxepine | |
| TNSN05238A1 (fr) | Derives du benzenesulfonamide, leur procede de preparation et leur utilisation pour le traitement de la douleur |